Publications

Heart Failure

Poster on Pharmacokinetic and Pharmacodynamic Response after Subcutaneous Administration of a Novel Furosemide Formulation (PDF)
Sica D, Muntendam P, de Boer R, Pitt B. Pharmacokinetic and Pharmacodynamic Response after Subcutaneous Administration of a Novel Furosemide Formulation. Rapid-Fire Abstract Session presented at: HFSA2016 20th Annual Scientific Meeting; 2016 Sep 17-20; Orlando, FL.

Poster on Subcutaneous Versus Intravenous Furosemide in the Johns Hopkins Heart Failure Bridge Clinic (PDF)
Princewill O, Okwuosa I, Almansa J, Cummings A, Cuomo K, Russell S. Efficacy and Safety of Subcutaneous vs Intravenous Furosemide in an Ambulatory Heart Failure Population. Poster session presented at: HFSA2016 20th Annual Scientific Meeting; 2016 Sep 17-20; Orlando, FL.

scPharmaceuticals in the News: MD Magazine Interviews Pieter Muntendam

On September 19, 2016, as part of their HFSA2016 Conference coverage, MD Magazine publishes “Interview with Pieter Muntendam: Reducing Patients’ Hospital Stay,” a video interview.

Article on Clinical Experience with Subcutaneous Furosemide

Goenaga MA, Millet M, Sánchez E, Garde C, Carrera JA, Arzellus E. Subcutaneous furosemide. Ann Pharmacother. 2004 Oct;38(10):1751. Epub 2004 Aug 31. PubMed PMID: 15340122.

Article on Clinical Experience with Subcutaneous Furosemide

Farless LB, Steil N, Williams BR, Bailey FA. Intermittent Subcutaneous Furosemide: Parenteral Diuretic Rescue for Hospice Patients with Congestive Heart Failure Resistant to Oral Diuretic. Am J Hosp Palliat Care. 2012 Nov 6. [Epub ahead of print] PubMed PMID: 23136114.

Article on Clinical Experience with Subcutaneous Furosemide

Zacharias H, Raw J, Nunn A, Parsons S, Johnson M. Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure? Palliat Med. 2011 Sep;25(6):658-63. doi: 10.1177/0269216311399490. Epub 2011 Mar 11. Review. PubMed PMID: 21398345.

Human Volunteer Pharmacodynamics Study with Subcutaneous Furosemide

Verma AK, da Silva JH, Kuhl DR. Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study. Ann Pharmacother. 2004 Apr;38(4):544-9. Epub 2004 Feb 24. PubMed PMID: 14982985.

Article on Furosemide Dosing in Management of Decompensated Heart Failure

Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O'Connor CM; NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011 Mar 3;364(9):797-805. doi: 10.1056/NEJMoa1005419. PubMed PMID: 21366472; PubMed Central PMCID: PMC3412356.

OPAT: Outpatient Antimicrobial Therapy

Poster on Pharmacokinetic Response after Subcutaneous Administration of Ceftriaxone  (PDF)
Muntendam P, Myers RL, Shearer TW.  Pharmacokinetic Response after Subcutaneous Administration of Ceftriaxone. Poster session at: IDWeek 2016 Meeting; 2016 October 26-28; New Orleans, LA

February 25, 2016

Article on Vascular Access Complications During OPAT at Home

Shrestha NK, Shrestha J, Everett A, Carroll D, Gordon SM, Butler RS, Rehm SJ. Vascular access complications during outpatient parenteral antimicrobial therapy at home: a retrospective cohort study. J Antimicrob Chemother. 2016 Feb;71(2):506-12. doi: 10.1093/jac/dkv344. Epub 2015 Oct 28.

February 25, 2016

Article on Patient Characteristics and OPAT Treatment Factors Associated with Increased Risk of OPAT-related Complications

Felder KK, Marshall LM, Vaz LE, Barnes PD. Risk Factors for Complications during Outpatient Parenteral Antimicrobial Therapy for Adult Orthopedic and Neurosurgical Infections. South Med J. 2016 Jan;109(1):53-60. doi: 10.14423/SMJ.0000000000000401.